Compare Gemini Space Station Inc (GEMI) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gemini Space Station Inc vs Zimmer Biomet Holdings Inc — how do they compare? Gemini Space Station Inc trades at $4.4 (market cap $579.55M), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 29.2× Gemini Space Station Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while Gemini Space Station Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gemini Space Station Inc for 14 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| GEMI | ZBH | |
|---|---|---|
Market Cap | $579.55M | $16.95B |
Volume | 1,882,406 | 2,505,240 |
Sector | Financials | Health |
52-Week High | $25.41 | $103.98 |
52-Week Low | $3.54 | $79.58 |
Typical Hold Time | 14 Days | 89 Days |
Enterprise Value | $558.57M | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gemini Space Station (GEMI) trades at $4.395, down 2.12% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue growth of 37% year-over-year but missed earnings estimates with a net loss of -$0.89 per share. Despite negative profitability margins, analyst consensus price target is $5.25 with 33% buy ratings. Recent news highlights expansion into commission-free stock trading and ongoing securities litigation.
The stock faces significant fundamental challenges with negative profit margins and cash burn, though revenue growth and new business initiatives provide potential catalysts. High volatility and legal risks weigh on investor sentiment, creating a speculative opportunity for those betting on the company's super app strategy amid cautious Wall Street coverage.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
